The International Cooperation Department of the China Securities Regulatory Commission issued a notification on the registration of the fully circulating unlisted domestic shares of Yiming Anke Biomedical Technology (Shanghai) Co., Ltd. Seven shareholders of the company intend to convert a total of 14,114,006 shares of unlisted domestic shares into overseas listed shares and list them for circulation on the Hong Kong Stock Exchange.
Clear
All
Quotes
News
Learn
Help
All
HK
US
CN
SG
AU
JP
All
News
Announcements
Reports
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
-
Intel reached its largest increase since March 2020! The company welcomed "the CEO who understands the Chinese Semiconductors market the best."
Breaking news in the Hong Kong stock market! The Hong Kong Stock Exchange is discussing lowering the investment threshold for High Stock Price stocks.
Futu Holdings Ltd announced its financial results for Q4 2024 and the entire year: Global business is experiencing rapid growth, with Q4 net profit increasing by 105% year-on-year.
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
宜明昂科境内未上市股份“全流通”获中国证监会备案
The unlisted domestic shares of Yiming Anke have been fully converted and approved by the China Securities Regulatory Commission.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Like
Views 349
Write a comment
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report